{'fraction_non_alphanumeric': 0.0582053354890865, 'fraction_numerical': 0.04042037186742118, 'mean_word_length': 4.4298245614035086, 'pattern_counts': {'":': 0, '<': 1, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
The association between admission blood urea nitrogen levels with in-hospital and long-term mortality in ST-segment elevation myocardial infarction

BACKROUND:  The aim of this study was to investigate the association of blood urine nitrogen (BUN) levels with all-cause mortality in ST-segment elevation myocardial infarction (STEMI). METHODS:  This study included 3778 patients with STEMI  treated  with primary percutaneous coronary intervention . An  admission BUN of 17.5 mg/dL was identified through a ROC analysis as an optimal cutoff value to predict the in-hospital mortality with 68% sensitivity and 66% specificity (AUC: 0.75; 95% CI:0.72-0.88; p < 0.001). RESULTS: The patients were followed up for a mean period of  33±0.14  months.  Patients with higher BUN levels had 5.3-times higher in-hospital (OR: 6.0, 95% CI: 4.4-8.3) and  5-times higher long-term (HR: 5.3, 95% CI: 4.2-6.8) mortality rates than patients with lower BUN levels. CONCLUSIONS:  This study demonstrated that elevated BUN level was independently associated with increased in-hospital and long-term mortality. BUN test is simple, inexpensive, and easily bedside applicable method. Hence, it can be used to detect high-risk patients in the setting of STEMI.